Exact Mass: 792.337

Exact Mass Matches: 792.337

Found 35 metabolites which its exact mass value is equals to given mass value 792.337, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Bn-NCC-2

6-[3-(2-carboxyethyl)-5-[(4-ethenyl-3-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)methyl]-4-methyl-1H-pyrrol-2-yl]-2-{[5-formyl-4-methyl-3-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)-1H-pyrrol-2-yl]methyl}-3-methyl-4-oxo-1H,4H,5H,6H-cyclopenta[b]pyrrole-5-carboxylic acid

C40H48N4O13 (792.3218)


Bn-NCC-2 is found in brassicas. Bn-NCC-2 is isolated from rape cotyledons. Isolated from rape cotyledons. Bn-NCC-2 is found in brassicas.

   

Triplostoside A

Triplostoside A

C35H52O20 (792.3052)


   

2-[(2S*,3R*,4S*)-3-ethenyl-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2H-pyran-4-yl]ethyl (2S*,3R*,4S*)-4-(2,2-dimethoxyethyl)-3-ethenyl-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-5-carboxylate|tripterospermumcin B

2-[(2S*,3R*,4S*)-3-ethenyl-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2H-pyran-4-yl]ethyl (2S*,3R*,4S*)-4-(2,2-dimethoxyethyl)-3-ethenyl-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-5-carboxylate|tripterospermumcin B

C35H52O20 (792.3052)


   
   

beta-D-glucopyranosyl-(1->2)-[beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->6)]-1-O-octanoyl-beta-D-glucopyranose|nonioside T

beta-D-glucopyranosyl-(1->2)-[beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->6)]-1-O-octanoyl-beta-D-glucopyranose|nonioside T

C32H56O22 (792.3263)


   
   
   

methyl 2-diphenylphosphanyl-4-[3-[2-[2-[3-[5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoylamino]propoxy]ethoxy]ethoxy]propylcarbamoyl]benzoate

methyl 2-diphenylphosphanyl-4-[3-[2-[2-[3-[5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoylamino]propoxy]ethoxy]ethoxy]propylcarbamoyl]benzoate

C41H53N4O8PS (792.3322)


   

Aluminum coprogen [M+Al-2H]

Aluminum coprogen [M+Al-2H]

C35H53AlN6O13 (792.3486)


   

Phosphine-biotin

methyl 2-(diphenylphosphino)-4-(15-oxo-19-(2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-4,7,10-trioxa-14-azanonadecylcarbamoyl)benzoate

C41H53N4O8PS (792.3322)


   

Bn-NCC-2

6-[3-(2-carboxyethyl)-5-[(4-ethenyl-3-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)methyl]-4-methyl-1H-pyrrol-2-yl]-2-{[5-formyl-4-methyl-3-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)-1H-pyrrol-2-yl]methyl}-3-methyl-4-oxo-1H,4H,5H,6H-cyclopenta[b]pyrrole-5-carboxylic acid

C40H48N4O13 (792.3218)


   

tert-butyl 2-[2-[2-[2-[bis[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]amino]-5-bromophenoxy]ethoxy]-4-methyl-N-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]anilino]acetate

tert-butyl 2-[2-[2-[2-[bis[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]amino]-5-bromophenoxy]ethoxy]-4-methyl-N-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]anilino]acetate

C39H57BrN2O10 (792.3196)


   

N,N,N,N-Tetrakis(biphenyl-4-yl)benzidine

N,N,N,N-Tetrakis(biphenyl-4-yl)benzidine

C60H44N2 (792.3504)


   

(Tetra-t-butylphthalocyaninato)iron(II)

(Tetra-t-butylphthalocyaninato)iron(II)

C48H48FeN8 (792.3351)


   

Cenicriviroc mesylate

Cenicriviroc mesylate

C42H56N4O7S2 (792.359)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist D065100 - CCR5 Receptor Antagonists

   

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C41H61O13P (792.385)


   

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C41H61O13P (792.385)


   
   
   
   
   
   

Galnon (TFA)

Galnon (TFA)

C42H47F3N4O8 (792.3346)


Galnon TFA is a selective and non-peptide agonist of galanin GAL1 and GAL2 receptor, with Kis of 11.7 and 34.1 μM respectively. Galnon TFA exhibits anticonvulsant and anxiolytic effects[1][2].

   

(1r,3s,3ar,4r,5r,6r,7as)-6-[(1s,2r,3r,4s,6s)-4-(acetyloxy)-6-hydroxy-2-(2-methoxy-2-oxoethyl)-1,3-dimethyl-7,9-dioxabicyclo[4.2.1]nonan-3-yl]-5-(formyloxy)-3-(furan-3-yl)-7a-hydroxy-3a-methyl-7-methylidene-1-[(2-methylpropanoyl)oxy]-hexahydroinden-4-yl (2r,3r)-2-hydroxy-3-methylpentanoate

(1r,3s,3ar,4r,5r,6r,7as)-6-[(1s,2r,3r,4s,6s)-4-(acetyloxy)-6-hydroxy-2-(2-methoxy-2-oxoethyl)-1,3-dimethyl-7,9-dioxabicyclo[4.2.1]nonan-3-yl]-5-(formyloxy)-3-(furan-3-yl)-7a-hydroxy-3a-methyl-7-methylidene-1-[(2-methylpropanoyl)oxy]-hexahydroinden-4-yl (2r,3r)-2-hydroxy-3-methylpentanoate

C40H56O16 (792.3568)


   

(6-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl 3,5-bis(3-hydroxy-3-methylbut-1-en-1-yl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoate

(6-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl 3,5-bis(3-hydroxy-3-methylbut-1-en-1-yl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoate

C35H52O20 (792.3052)


   

13,29-dimethyl (1r,3r,6r,14r,17r,19r,22r,30r)-9,25-dimethoxy-4,20-dioxo-5,21-dioxa-13,29,36,42-tetraazaundecacyclo[20.10.6.6⁶,¹⁷.0¹,³⁶.0³,³⁰.0⁶,¹⁴.0⁷,¹².0¹⁴,¹⁹.0²²,³⁰.0²³,²⁸.0¹⁷,⁴²]tetratetraconta-7,9,11,23,25,27,33,39-octaene-13,29-dicarboxylate

13,29-dimethyl (1r,3r,6r,14r,17r,19r,22r,30r)-9,25-dimethoxy-4,20-dioxo-5,21-dioxa-13,29,36,42-tetraazaundecacyclo[20.10.6.6⁶,¹⁷.0¹,³⁶.0³,³⁰.0⁶,¹⁴.0⁷,¹².0¹⁴,¹⁹.0²²,³⁰.0²³,²⁸.0¹⁷,⁴²]tetratetraconta-7,9,11,23,25,27,33,39-octaene-13,29-dicarboxylate

C44H48N4O10 (792.337)


   

[(2r,3s,4s,5r,6r)-6-{[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl 3,5-bis[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoate

[(2r,3s,4s,5r,6r)-6-{[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl 3,5-bis[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoate

C35H52O20 (792.3052)


   

6-[4-(acetyloxy)-6-hydroxy-2-(2-methoxy-2-oxoethyl)-1,3-dimethyl-7,9-dioxabicyclo[4.2.1]nonan-3-yl]-5-(formyloxy)-3-(furan-3-yl)-7a-hydroxy-3a-methyl-7-methylidene-1-[(2-methylpropanoyl)oxy]-hexahydroinden-4-yl 2-hydroxy-3-methylpentanoate

6-[4-(acetyloxy)-6-hydroxy-2-(2-methoxy-2-oxoethyl)-1,3-dimethyl-7,9-dioxabicyclo[4.2.1]nonan-3-yl]-5-(formyloxy)-3-(furan-3-yl)-7a-hydroxy-3a-methyl-7-methylidene-1-[(2-methylpropanoyl)oxy]-hexahydroinden-4-yl 2-hydroxy-3-methylpentanoate

C40H56O16 (792.3568)


   

4-(methoxycarbonyl)-7-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-6-yl 4-(2,2-dimethoxyethyl)-5-ethenyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

4-(methoxycarbonyl)-7-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-6-yl 4-(2,2-dimethoxyethyl)-5-ethenyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

C35H52O20 (792.3052)


   

13,29-dimethyl 9,25-dimethoxy-4,20-dioxo-5,21-dioxa-13,29,36,42-tetraazaundecacyclo[20.10.6.6⁶,¹⁷.0¹,³⁶.0³,³⁰.0⁶,¹⁴.0⁷,¹².0¹⁴,¹⁹.0²²,³⁰.0²³,²⁸.0¹⁷,⁴²]tetratetraconta-7,9,11,23,25,27,33,39-octaene-13,29-dicarboxylate

13,29-dimethyl 9,25-dimethoxy-4,20-dioxo-5,21-dioxa-13,29,36,42-tetraazaundecacyclo[20.10.6.6⁶,¹⁷.0¹,³⁶.0³,³⁰.0⁶,¹⁴.0⁷,¹².0¹⁴,¹⁹.0²²,³⁰.0²³,²⁸.0¹⁷,⁴²]tetratetraconta-7,9,11,23,25,27,33,39-octaene-13,29-dicarboxylate

C44H48N4O10 (792.337)


   

(1s,4as,6s,7r,7as)-4-(methoxycarbonyl)-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-6-yl (4s,5r,6s)-4-(2,2-dimethoxyethyl)-5-ethenyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

(1s,4as,6s,7r,7as)-4-(methoxycarbonyl)-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-6-yl (4s,5r,6s)-4-(2,2-dimethoxyethyl)-5-ethenyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

C35H52O20 (792.3052)


   

(1s,4ar,6s,7s,7ar)-4-(methoxycarbonyl)-7-methyl-1-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-6-yl (4r,5r,6s)-4-(2,2-dimethoxyethyl)-5-ethenyl-6-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

(1s,4ar,6s,7s,7ar)-4-(methoxycarbonyl)-7-methyl-1-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-6-yl (4r,5r,6s)-4-(2,2-dimethoxyethyl)-5-ethenyl-6-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

C35H52O20 (792.3052)


   

hydroxy(3,4,5,6-tetrahydroxyoxan-2-yl)methyl (2s,4s,8s,9s,10s,12r,13r,16r,17s,18r)-16-(acetyloxy)-2-[(acetyloxy)methyl]-10-hydroxy-9,13,17-trimethyl-7-(4-methyl-2-oxopent-3-en-1-yl)-6-oxo-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-1(20)-ene-17-carboxylate

hydroxy(3,4,5,6-tetrahydroxyoxan-2-yl)methyl (2s,4s,8s,9s,10s,12r,13r,16r,17s,18r)-16-(acetyloxy)-2-[(acetyloxy)methyl]-10-hydroxy-9,13,17-trimethyl-7-(4-methyl-2-oxopent-3-en-1-yl)-6-oxo-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-1(20)-ene-17-carboxylate

C40H56O16 (792.3568)